___

• 1. Owens MJ, Nemeroff CB. Pharmacology of valproate. Psychopharmacol Bull 2003; 37 Suppl 2: 17-24.
• 2. Dhamija R, Gavrilova RH, Wirrell EC. Valproate-induced worsening of seizures: clue to underlying diagnosis. J Child Neurol 2011; 26: 1319-21.
• 3. Verrotti A, Greco R, Morgese G, Chiarelli F. Carnitine defciency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 1999; 29: 36-40.
• 4. Gerstner T, Buesing D, Longin E, et al. Valproic acid induced encephalopathy- -19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children. Seizure 2006; 15: 443-8.
• 5. Dinopoulos A, Matsubara Y, Kure S. Atypical variants of nonketotic hyperglycinemia. Mol Genet Metab 2005; 86: 61-9.
• 6. Kochi H, Hayasaka K, Hiraga K, Kikuchi G. Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia. Arch Biochem Biophys 1979; 198: 589-97.
• 7. Gerstner T, Bell N, König S. Oral valproic acid for epilepsy--long-term experience in therapy and side effects. Expert Opin Pharmacother 2008; 9: 285-92.